https://www.globenewswire.com/fr/news-release/2020/11/02/2118312/0/en/Jounce-Therapeutics-Announces-Update-on-Vopratelimab-Program.html
Jounce Therapeutics Announces Update on Vopratelimab
- No further enrollment in EMERGE trial of vopratelimab in combination with ipilimumab based on interim analysis- - First patient dosed in SELECT trial of...
jouncetherapeuticsannouncesupdate